Related Experiment Video
Updated: Jun 23, 2026

12:08
Telomere Length and Telomerase Activity; A Yin and Yang of Cell Senescence
Published on: May 22, 2013
Telomere length as a biological marker in malignancy.
1Department of Medical Biosciences, Umeå University, SE-90187 Umeå, Sweden.
Biochimica Et Biophysica Acta
|May 8, 2009
Summary
Telomere length (TL) is crucial for cancer cell survival and is a promising clinical marker for predicting cancer risk and prognosis. Measuring TL in tumors and healthy tissues offers insights for future cancer treatment strategies.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Telomere maintenance is vital for tumor cell proliferation and survival.
- Telomere length (TL) is regulated by factors influencing telomere homeostasis.
- Recent advancements highlight TL's potential as a clinical biomarker in oncology.
Purpose of the Study:
- To review the current status of telomere length (TL) as a biological marker in cancer patients.
- To explore the significance of TL in tumor progression and patient prognosis.
- To discuss the clinical implications of TL measurements in oncology.
Main Methods:
- Literature review of studies on telomere length in cancer.
- Analysis of the role of telomere maintenance in malignant disorders.
- Evaluation of TL as a predictive marker for cancer risk and prognosis.
Main Results:
- Telomere length is a key factor in tumor cell growth and survival.
- TL measurements in both tumor and peripheral blood samples provide valuable prognostic information.
- TL has emerged as a significant biomarker in the last decade.
Conclusions:
- Telomere length serves as a critical biological marker in cancer patients.
- TL assessment in tumors and healthy tissues can inform future therapeutic strategies.
- Further research into TL is warranted for improved cancer management.
Related Concept Videos
Replicative Cell Senescence
Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds the telomeric...
lncRNA - Long Non-coding RNAs
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA (lncRNA)...
Telomeres and Telomerase
In eukaryotic DNA replication, a single-stranded DNA fragment remains at the end of a chromosome after the removal of the final primer. This section of DNA cannot be replicated in the same manner as the rest of the strand because there is no 3’ end to which the newly synthesized DNA can attach. This non-replicated fragment results in gradual loss of the chromosomal DNA during each cell duplication. Additionally, it can induce a DNA damage response by enzymes that recognize single-stranded DNA.
Telomeres and Telomerase
In eukaryotic DNA replication, a single-stranded DNA fragment remains at the end of a chromosome after the removal of the final primer. This section of DNA cannot be replicated in the same manner as the rest of the strand because there is no 3’ end to which the newly synthesized DNA can attach. This non-replicated fragment results in gradual loss of the chromosomal DNA during each cell duplication. Additionally, it can induce a DNA damage response by enzymes that recognize single-stranded DNA.
Non-LTR Retrotransposons
As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...

